Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy. [PDF]
Yao L +14 more
europepmc +1 more source
De Novo Synthesis in Cancer Immunotherapy: Applications and Prospects. [PDF]
Jin Y, Wu Y, Luo J.
europepmc +1 more source
Clinical Translation of Functional Magnetic Nanoparticles for Intracellular Hyperthermia and Cancer Immunotherapy. [PDF]
Fukushima T, Kaneko M, Ito A.
europepmc +1 more source
HDAC2 restrains IGF2BP1-associated m6A dysregulation in cervical cancer immunotherapy resistance. [PDF]
Deng Q +6 more
europepmc +1 more source
Immunological consequences of chemotherapy: implications for cancer immunotherapy. [PDF]
Bishara GG +4 more
europepmc +1 more source
Antigen presentation requirements for effective cDC1-based cancer immunotherapy. [PDF]
Pineda JE +12 more
europepmc +1 more source
From Mechanism to Clinic: Engineered Bacteria-Nanomaterial Hybrid Systems for Cancer Immunotherapy. [PDF]
Lin J +8 more
europepmc +1 more source
Psychological distress as a putative host-state determinant of cancer immunotherapy response. [PDF]
Bronisz A, Kiel K, Godlewski J.
europepmc +1 more source
Myotoxicity in the era of cancer immunotherapy: from mechanisms to multidisciplinary management. [PDF]
de la Brassinne Bonardeaux O +5 more
europepmc +1 more source

